SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549-1004

                                    FORM 8-K

                    CURRENT REPORT PURSUANT TO SECTION 13 OF
                       THE SECURITIES EXCHANGE ACT OF 1934


      DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  SEPTEMBER 26, 2000

                                   GENUS, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

     CALIFORNIA                          0-17139                94-2790804
(STATE OR OTHER JURISDICTION OF   [COMMISSION FILE NUMBER]    (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)                                   ID NUMBER)



                                 1139 KARLSTAD DRIVE
                                 SUNNYVALE, CA  94089
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

                                 (408) 747-7120
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
<PAGE>

ITEM  5.  OTHER  EVENTS
     On  September  26, 2000, Genus, Inc. issued a press release announcing that
the  Board  of Directors of Genus, Inc. had approved the adoption of a Preferred
Stock  Rights  Agreement.  The press release is attached as Exhibit 99.2 to this
Form  8-K.
ITEM  7.  FINANCIAL  STATEMENTS  AND  EXHIBITS


     (c)     Exhibits.


EXHIBIT
NUMBER                          DESCRIPTION
-----------------------------------------------------------------
99.2        Genus, Inc. Press Release issued September 26, 2000.



                                    SIGNATURE
     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.


                                              GENUS,  INC.
                                              (Registrant)


Date:  September  26,  2000

                                               By:     /s/  Kenneth  Schwanda
                                                       ----------------------
                                                       Kenneth  Schwanda
                                                       Chief  Financial  Officer

<PAGE>


EXHIBIT  INDEX


EXHIBIT
NUMBER                       DESCRIPTION
-------
99.2     Genus, Inc. Press Release, issued September 26, 2000


<PAGE>


COMPANY  CONTACT:                          EDITORIAL  CONTACT:
Debra  Scott                               Steve  Farnsworth
Genus,  Inc.                               Positio
Tel:  (408) 747-7120 Ext. 1407             Tel:  (650) 815-1006 Ext.103
Fax:  (408)  747-7199                      Fax:  (650)  815-1095


FOR  IMMEDIATE  RELEASE:

                 GENUS ADOPTS AMENDED SHAREHOLDERS' RIGHTS PLAN

SUNNYVALE,  Calif.,  September  26, 2000 -- Genus, Inc. (Nasdaq: GGNS) announced
today  that  its  board  of  directors  has  updated  its previous Common Shares
Purchase  Rights Plan with a Preferred Shares Purchase Rights Plan.  As with the
original  plan,  the amended plan is designed to protect Genus shareholders from
coercive  or  unfair  takeover tactics in the event of an unsolicited attempt to
form a business combination. The plan is similar to plans adopted by many public
companies.  Genus  management  added  that  it  is  not  aware  of  any takeover
proposals  at  this  time.

Under  the  plan,  Genus  will  issue  a dividend of one right for each share of
common stock of Genus held by shareholders of record as of the close of business
on  October  13,  2000.  These  rights will initially trade with shares of Genus
Common  Stock  and  will  not  be  immediately  exercisable.

The  rights  will  become  exercisable ten business days after a person or group
announces  acquisition  of 15% or more of Genus' outstanding Common Stock or ten
business  days  after  the  commencement  of a tender offer that would result in
ownership of 15% or more of Genus' Common Stock, if such action is taken without
the approval of the board of directors of Genus.  If exercised, the rights would
significantly dilute the Genus holdings of the would-be acquiror by allowing all
shareholders,  except the acquiror, to purchase shares of Genus at a price equal
to  one-half  of  the  then-current  trading  price.  The  terms  of  the rights
agreement may be amended by the board of directors at any time prior to the date
on  which  the  rights  become exercisable.  Further details of the plan will be
mailed  to  stockholders  following  the  record  date.
                                      # # #

AboutGenus
----------
Founded  in  1982,  Genus,  Inc.,  designs,  manufactures  and  markets  capital
equipment  and  deposition  processes  for advanced semiconductor manufacturing.
The  company's  thin  film  deposition  products  are  used worldwide to produce
integrated  circuits for the data processing, communications, medical, military,
transportation  and  consumer  electronics industries.  Genus' customers include
semiconductor manufacturers located throughout the United States, Europe and the
Pacific  Rim  including  Korea,  Japan  and  Taiwan.  Genus  is headquartered in
Sunnyvale,  California.  For  additional  company,  product  and  financial
information,  visit  Genus'  web  site  at  www.genus.com.
[{"type": "8-K", "sequence": "1", "filename": "0001.txt", "secsgml_size_bytes": 5322}]
{"company-data": {"conformed-name": "GENUS INC", "cik": "0000837913", "assigned-sic": "3559", "irs-number": "942790804", "state-of-incorporation": "CA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-17139", "film-number": "729247"}, "business-address": {"street1": "1139 KARLSTAD DR", "city": "SUNNYVALE", "state": "CA", "zip": "94089-2117", "phone": "4087477120"}, "mail-address": {"street2": "1139 KARLSTAD DR", "city": "SUNNYVALE", "state": "CA", "zip": "94089-2117"}}
SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549-1004

                                    FORM 8-K

                    CURRENT REPORT PURSUANT TO SECTION 13 OF
                       THE SECURITIES EXCHANGE ACT OF 1934

      DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  SEPTEMBER 26, 2000

                                   GENUS, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

     CALIFORNIA                          0-17139                94-2790804
(STATE OR OTHER JURISDICTION OF   [COMMISSION FILE NUMBER]    (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)                                   ID NUMBER)

                                 1139 KARLSTAD DRIVE
                                 SUNNYVALE, CA  94089
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

                                 (408) 747-7120
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
ITEM  5.  OTHER  EVENTS
     On  September  26, 2000, Genus, Inc. issued a press release announcing that
the  Board  of Directors of Genus, Inc. had approved the adoption of a Preferred
Stock  Rights  Agreement.  The press release is attached as Exhibit 99.2 to this
Form  8-K.
ITEM  7.  FINANCIAL  STATEMENTS  AND  EXHIBITS

     (c)     Exhibits.

EXHIBIT
NUMBER                          DESCRIPTION
-----------------------------------------------------------------
99.2        Genus, Inc. Press Release issued September 26, 2000.

                                    SIGNATURE
     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.

                                              GENUS,  INC.
                                              (Registrant)

Date:  September  26,  2000

                                               By:     /s/  Kenneth  Schwanda
                                                       ----------------------
                                                       Kenneth  Schwanda
                                                       Chief  Financial  Officer
EXHIBIT  INDEX

EXHIBIT
NUMBER                       DESCRIPTION
-------
99.2     Genus, Inc. Press Release, issued September 26, 2000
COMPANY  CONTACT:                          EDITORIAL  CONTACT:
Debra  Scott                               Steve  Farnsworth
Genus,  Inc.                               Positio
Tel:  (408) 747-7120 Ext. 1407             Tel:  (650) 815-1006 Ext.103
Fax:  (408)  747-7199                      Fax:  (650)  815-1095

FOR  IMMEDIATE  RELEASE:

                 GENUS ADOPTS AMENDED SHAREHOLDERS' RIGHTS PLAN

SUNNYVALE,  Calif.,  September  26, 2000 -- Genus, Inc. (Nasdaq: GGNS) announced
today  that  its  board  of  directors  has  updated  its previous Common Shares
Purchase  Rights Plan with a Preferred Shares Purchase Rights Plan.  As with the
original  plan,  the amended plan is designed to protect Genus shareholders from
coercive  or  unfair  takeover tactics in the event of an unsolicited attempt to
form a business combination. The plan is similar to plans adopted by many public
companies.  Genus  management  added  that  it  is  not  aware  of  any takeover
proposals  at  this  time.

Under  the  plan,  Genus  will  issue  a dividend of one right for each share of
common stock of Genus held by shareholders of record as of the close of business
on  October  13,  2000.  These  rights will initially trade with shares of Genus
Common  Stock  and  will  not  be  immediately  exercisable.

The  rights  will  become  exercisable ten business days after a person or group
announces  acquisition  of 15% or more of Genus' outstanding Common Stock or ten
business  days  after  the  commencement  of a tender offer that would result in
ownership of 15% or more of Genus' Common Stock, if such action is taken without
the approval of the board of directors of Genus.  If exercised, the rights would
significantly dilute the Genus holdings of the would-be acquiror by allowing all
shareholders,  except the acquiror, to purchase shares of Genus at a price equal
to  one-half  of  the  then-current  trading  price.  The  terms  of  the rights
agreement may be amended by the board of directors at any time prior to the date
on  which  the  rights  become exercisable.  Further details of the plan will be
mailed  to  stockholders  following  the  record  date.
                                      # # #

AboutGenus
----------
Founded  in  1982,  Genus,  Inc.,  designs,  manufactures  and  markets  capital
equipment  and  deposition  processes  for advanced semiconductor manufacturing.
The  company's  thin  film  deposition  products  are  used worldwide to produce
integrated  circuits for the data processing, communications, medical, military,
transportation  and  consumer  electronics industries.  Genus' customers include
semiconductor manufacturers located throughout the United States, Europe and the
Pacific  Rim  including  Korea,  Japan  and  Taiwan.  Genus  is headquartered in
Sunnyvale,  California.  For  additional  company,  product  and  financial
information,  visit  Genus'  web  site  at  www.genus.com.